Effect of electro-acupuncture on ovarian function of women with diminished ovarian reserve: study protocol for a randomized controlled trial

Le Yang, Hanwang Zhang, Li Zhou, Ying Gao, Lijuan Yang, Yajun Hu, Lu Xu, Dongmei HuangTrials 2021 · DOI

TL;DR

This paper presents a rigorous protocol for a multicenter randomized controlled trial (RCT) designed to determine if electro-acupuncture (EA) can improve clinical pregnancy rates in women with diminished ovarian reserve (DOR). By integrating traditional Chinese medicine with modern IVF-ET (In-vitro fertilization-embryo transfer), the study seeks to provide high-quality evidence for a non-pharmacological intervention to boost fertility outcomes.

What Problem Does This Paper Address?

Diminished ovarian reserve (DOR) is a condition where the quantity and quality of a woman's oocytes are reduced before the age of 40. It is often a precursor to premature ovarian failure and significantly hinders the success of IVF treatments, leading to lower embryo quality and higher miscarriage rates.

Currently, there is no effective pharmacotherapy to "reverse" or significantly stall DOR. While some small-scale or non-randomized studies suggest that acupuncture might improve ovarian microenvironments and regulate the neuro-endocrine system, the field lacks large-scale, blinded, multicenter evidence. This protocol aims to fill that gap by providing a standardized framework to test the efficacy and safety of electro-acupuncture as a clinical adjunct.

Methods

The study is designed as a multicenter, randomized, controlled superiority trial involving 338 participants across four hospitals in China.

  • Randomization: Participants are split 1:1 into a treatment group and a control group.
  • Treatment Group: Receives electro-acupuncture twice a week for 12 weeks prior to starting an IVF cycle. The protocol uses specific acupoints (e.g., GV20, CV6, ST29) and a low-frequency (2 Hz) electrical stimulation designed to evoke the "Deqi" sensation (a specific tingling or heaviness associated with effective acupuncture).
  • Control Group: Receives "sham" acupuncture at pseudo-acupoints with superficial needle insertion. Crucially, the electrical stimulators are turned on but set to zero intensity, and the "Deqi" sensation is intentionally avoided to maintain the placebo effect.
  • Blinding: While the acupuncturists cannot be blinded, the participants, outcome assessors, and statisticians are all blinded to the group assignments.
  • Primary Outcome: The clinical pregnancy rate per IVF cycle (confirmed by fetal heartbeat at 6–7 weeks).

Datasets

As this is a study protocol, there is no pre-existing dataset. The study defines the parameters for data collection from 338 women recruited from:

  1. Tongji Hospital (Wuhan)
  2. Union Hospital (Wuhan)
  3. Wuhan First Hospital
  4. Reproductive Hospital affiliated to Jiangxi University of Traditional Chinese Medicine.

The data will eventually include clinical outcomes, biochemical markers (AMH, FSH, E2), and psychological self-rating scales.

Key Insights and Ideas

  • The "Priming" Window: The study focuses on a 12-week intervention before the IVF cycle begins. This suggests the authors believe the primary benefit of EA lies in improving the baseline ovarian environment and follicular development rather than just assisting during the stimulation phase.
  • Neuro-Endocrine Focus: Beyond just pregnancy rates, the trial tracks biochemical markers like dopamine, norepinephrine, and corticotrophin-releasing hormone (CRH). This indicates an attempt to map the biological pathway—specifically how acupuncture might modulate the hypothalamic-pituitary-ovarian axis.
  • Rigorous Sham Control: One of the biggest hurdles in acupuncture research is the placebo effect. By using pseudo-acupoints and "silent" stimulators, this protocol attempts to meet the gold standard of clinical trial design.

Key Results

Quantitative results are not yet available as this is a protocol paper.

However, the authors' power analysis (assuming a 15% increase in pregnancy rates with a 20% dropout rate) led to the target sample size of 338, which is significantly larger than most previous studies in this niche.

Limitations and Future Work

  • Acupuncturist Blinding: It is physically impossible to blind the person performing the acupuncture, which introduces a potential source of bias in how the treatment is administered.
  • Complexity of Protocol: The authors acknowledge that the two-group acupoint rotation is "sophisticated," which may make it difficult for other clinics to replicate perfectly without specialized training.
  • Future Directions: If successful, this trial could lead to the standardization of electro-acupuncture as a routine "pre-treatment" for DOR patients. Future research would likely look into the cost-effectiveness of adding 12 weeks of acupuncture to already expensive IVF regimens.

Summary updated

Abstract

Chinese Clinical Trial Registry ChiCTR1900024626 . Registered on 19 July 2019.
BibTeX
@inproceedings{yang2021effect,
  author = {Le Yang and Hanwang Zhang and Li Zhou and Ying Gao and Lijuan Yang and Yajun Hu and Lu Xu and Dongmei Huang},
  title = {{Effect of electro-acupuncture on ovarian function of women with diminished ovarian reserve: study protocol for a randomized controlled trial}},
  booktitle = {Trials},
  year = {2021},
  doi = {10.1186/s13063-021-05894-2},
}
Figure